Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
Disease Category: Depression
Location: United States, CA
Clinical Trial Details
Research Study Summary
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder
To further characterize the efficacy, safety and tolerability of a single fixed dose level of velazodone (40 mg) relative to placebo in patients with moderate to severe major depressive disorder (MDD).
Patient Inclusion Criteria:
- Male or Female; 18-70 years of age; Body Mass Index between 18-40; negative urine drug screen; have normal physical examination findings; normal clinical laboratory and ECG results. Female of childbearing potential must have negative pregnancy screen.
Patient Exclusion Criteria:
- Positive drug screen; clinically significant concurrent medical history; woman who are pregnant, planning to become pregnant or breast feeding.
To Learn more
Both Male and Female
Date Last Changed:
July 18, 2013
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these